Rein Therapeutics secures up to $6.0M in prepaid advances from Yorkville; second $1.0M tranche drawn

Rein Therapeutics, Inc.

Entered Pre-Paid Advance Agreement with Yorkville for up to $6.0M over 12 months; initial $1.0M advance closed July 29, 2025.
As of Sept 8, 2025, 479,036 shares issued at avg $1.06 to Yorkville, offsetting $500K of initial advance.
Second $1.0M advance drawn on Sept 8, 2025 ($0.95M net proceeds); Yorkville may demand stock to reduce balance.
Advances have 8% interest (18% default), 12-month maturity; each advance sold at 95% of face amount.

item 1.01item 2.03item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.